The US stock market is likely to exhibit high volatility over the next two weeks. This is due to a combination of various economic and political factors that are increasing uncertainty among investors. Below is a summary of the main factors and outlook.

US Stock Market Outlook: Key Factors

#

1. Consumer Price Index (CPI) Release The CPI for February, scheduled to be released on March 13 (local time), is expected to have a significant impact on the market. If the CPI is reported higher than expected, the Federal Reserve (Fed) may delay interest rate cuts, which could negatively affect the market¹².
   • Previous CPI data recorded a 0.5% increase (exceeding expectations), while a 0.3% increase is anticipated this time¹.
2. Trade Policies and Tariffs President Donald Trump’s tariff policies are contributing to market anxiety. Additional tariffs on products imported from Canada, Mexico, and China are expected to negatively impact corporate profits and consumer prices³⁴.
   • Notably, the technology-centric Nasdaq index has already entered a correction phase, with the potential for further declines in the short term⁵².
3. Federal Government Shutdown Risk The risk of a federal government shutdown may continue through the end of next week, potentially worsening investor sentiment³.
4. Concerns About Economic Growth Slowdown Recent employment reports and consumer indicators suggest a slowdown in economic growth, which could lead to reduced corporate investment and employment⁴⁶. This concern may exert bearish pressure across the market.

Outlook for the Next Two Weeks

#

• Short-Term Decline Potential: High inflation data and uncertainty around tariff policies pose significant risks to the market in the short term. Particularly, the S&P 500 and Nasdaq may undergo additional corrections¹².
• Increased Volatility: Market volatility is expected to significantly increase in response to economic data releases and policy changes. Some experts warn that the S&P 500 may drop 14-20% in the short term⁷².
• Temporary Rebound Possibility: Should positive economic data or policy changes emerge, the market might attempt a rebound. However, this is likely to be temporary³².

Conclusion

#

The next two weeks will be crucial for the US stock market. Investors should closely monitor inflation data, the Fed’s policy direction, and trade and political risks. A cautious investment strategy is necessary in a highly volatile environment.

---

The Likelihood of the US Stock Market Recovering from Current Struggles

#

The likelihood of the US stock market recovering from its current challenges appears to vary depending on several economic and policy factors. Recent market declines have occurred amidst high volatility and uncertainty; however, certain positive elements suggest a potential for recovery.

Factors Supporting Recovery Potential

#

1. Expectation of Tariff Reductions President Donald Trump’s hints at tariff adjustments with Canada and Mexico have partially restored investor confidence, which could serve as a positive factor for a short-term rebound⁸⁹.
2. Federal Reserve’s Interest Rate Policy Concerns about economic growth slowdown and low employment indicators may lead the Fed to enact additional interest rate cuts. This could have a positive impact on the market, and investors are paying attention to this¹⁰¹¹.
3. Historical Recovery Patterns Data from the past 150 years indicate that the US stock market has always recovered after various shocks, eventually reaching new highs. This supports a long-term optimism about the current market situation¹².
4. US Economic Outlook for 2025 Experts forecast stable economic growth for the US in 2025, mentioning the potential for increased corporate profits and a sustained strength in AI and tech stocks. These factors could support stock market recovery¹³¹⁴¹⁵.

Risk Factors That May Hinder Recovery

#

1. High Inflation If the consumer price index (CPI) released this week is higher than expected, the Fed may delay interest rate cuts or maintain tight policies, which could negatively affect the market¹⁰¹¹.
2. Uncertainty Around Tariffs and Trade Policies Tariff policies from the Trump administration negatively impact corporate profits and consumer prices, worsening investor sentiment⁹¹⁶.
3. Concerns About Economic Growth Slowdown Recent employment indicators and economic data suggest a slowdown, which could exert bearish pressure across the market⁸¹¹.

Conclusion

#

While the US stock market is likely to experience sustained volatility in the short term, if expectations of tariff reductions and the Fed’s interest rate policy play out positively, there is potential for recovery. Considering historical data and the long-term outlook from experts, the market is expected to eventually enter a recovery phase. However, risks such as inflation and policy uncertainty should be closely monitored.

---

What is Neuralink?

#

Neuralink is a neurotechnology company founded by Elon Musk in 2016 that is developing a brain-computer interface (BCI) to connect the human brain directly to computers. Neuralink’s primary goal is to record and interpret neural signals through implantable devices in the brain, and to address various physical and neurological issues¹⁷¹⁸¹⁹.

Neuralink’s Technology and Operation

#

• Technology Overview: The device developed by Neuralink is a coin-sized chip called “the Link,” which is implanted under the skull. This chip records neural signals through thousands of microelectrodes implanted in the brain and can transmit signals back with electrical stimulation if needed¹⁷²⁰¹⁹.
• Operating Principle: Neuralink detects electrical signals generated by individual neurons and converts them into digital data. This data allows users to control devices or perform specific tasks just by thinking²¹²².
• Robot-Assisted Surgery: Neuralink has developed a robotic surgical system for precise device insertion, enabling safer and more accurate implantation than existing technologies²¹²⁰.

Key Application Areas

#

1. Restoration of Physical Function:
   • Helps paralyzed patients control limbs or assistive devices.
   • Aims to restore vision to visually impaired individuals or recover sensory and motor functions¹⁷¹⁸²³.
2. Treatment of Neurological Disorders:
   • Expected to be used in the treatment of various neurological disorders such as Alzheimer’s disease and Parkinson’s disease²⁰²³.
3. Cognitive Enhancement:
   • Potentially improves memory, concentration, and processing speed. Elon Musk likened it to a “fitness tracker for the skull”¹⁷¹⁸.
4. Integration with AI:
   • Long-term goals include integrating humans with artificial intelligence (AI) to achieve “symbiosis with AI.” Musk claims this could help humanity respond to the risks posed by advancements in AI technology²³¹⁹.

Current Status and Future Plans

#

As of January 2024, Neuralink successfully completed its first human implant trial, where a paralyzed patient demonstrated the ability to play chess or learn a new language¹⁷. Moving forward, Neuralink aims to commercialize its technology to benefit more individuals.

Neuralink is showcasing innovative technology in the brain-computer interface field and holds significant potential within the medical and technological industries.

---

What is the Current Progress?

#

Neuralink is currently in the early clinical trial stage, making significant advances in brain-computer interface (BCI) technology development. However, time is still needed before commercialization, as there are technical and ethical challenges to resolve. Below is a summary of Neuralink’s current progress.

Current Progress

#

1. Human Clinical Trials
   • Neuralink has successfully implanted brain implants in three individuals to date. The first patient received the implant in early 2024, the second in August 2024, and the third in early 2025²⁴²⁵²⁶.
   • These implants are allowing patients to move computer cursors or control smartphones just by thinking, and initial results have been positive²⁶²⁷.
2. FDA Approval and Expanded Research
   • Neuralink has received initial clinical trial approval from the US Food and Drug Administration (FDA) and is currently conducting a study called “PRIME Study” in the US and Canada. This research aims to help paralyzed patients control external devices²⁶²⁸.
   • In 2025, there are plans to implant additional devices in 20-30 patients, expanding the scope of research²⁵²⁷.
3. Technology Upgrades
   • Recent upgrades to the devices offer more electrodes, improved battery life, and higher data transfer bandwidth, enabling more precise signal interpretation²⁵²⁹.
   • Additionally, a new device called “Blindsight” is under development, aimed at restoring vision in visually impaired individuals²⁴²⁹.
4. Surgical Robot Improvements
   • Neuralink is using a surgical robot called R1 for inserting electrodes into the brain, and aims to achieve a faster and safer implantation process through automation²⁴²⁶.

Challenges

#

• Technical Stability: Some initial experiments have reported issues with electrodes functioning properly, which require ongoing improvements²⁴.
• Ethical Concerns: Ethical discussions continue regarding brain data privacy, security, and accessibility of the technology²⁹²⁷.
• Regulatory Approval: Additional approvals from regulatory agencies such as the FDA are needed for commercial product launches, which may take several years²⁴²⁹.

Conclusion

#

Neuralink has made substantial progress in developing brain-computer interface technology but is still in the early experimental stage and needs time before commercialization. In 2025, there will be further clinical trials and technology upgrades involving more patients, which will bring Neuralink closer to its goals for medical and technological innovation.